Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the efficacy of different dosing paradigms of PF-04523655 versus ranibizumab (comparator) in subjects with neovascular AMD.
Critère d'inclusion
- Subfoveal Choroidal Neovascularization (CNV) associated with Age-related Macular Degeneration (AMD)